Global Flu (Influenza) Vaccine Market Growth 2022-2028
- LP 4857531
- 107 Pages
- February 2022
- Pharmaceuticals
The United States Flu (Influenza) Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Flu (Influenza) Vaccine market, reaching US$ million by the year 2028. As for the Europe Flu (Influenza) Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Flu (Influenza) Vaccine players cover Hualan Bio, CCBIO, Aleph Biomedical, and SANOFI, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Flu (Influenza) Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Split Influenza Vaccine
Pandemic Influenza Vaccine
Subunit Influenza Vaccine
Quadrivalent Influenza Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
For Children (6 months to 3 years)
For Adults and Children over 3 years
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Hualan Bio
CCBIO
Aleph Biomedical
SANOFI
Adimmune
ZYAK
SINOVAC
Changsheng Biological
SIOBP
GSK
Aimei Hissen
Tianyuan Bio-pharma(Novartis)
Simcere Vaxtec
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Flu (Influenza) Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Flu (Influenza) Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Flu (Influenza) Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Flu (Influenza) Vaccine Segment by Type
2.2.1 Split Influenza Vaccine
2.2.2 Pandemic Influenza Vaccine
2.2.3 Subunit Influenza Vaccine
2.2.4 Quadrivalent Influenza Vaccine
2.3 Flu (Influenza) Vaccine Sales by Type
2.3.1 Global Flu (Influenza) Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Flu (Influenza) Vaccine Sale Price by Type (2017-2022)
2.4 Flu (Influenza) Vaccine Segment by Application
2.4.1 For Children (6 months to 3 years)
2.4.2 For Adults and Children over 3 years
2.5 Flu (Influenza) Vaccine Sales by Application
2.5.1 Global Flu (Influenza) Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Flu (Influenza) Vaccine Sale Price by Application (2017-2022)
3 Global Flu (Influenza) Vaccine by Company
3.1 Global Flu (Influenza) Vaccine Breakdown Data by Company
3.1.1 Global Flu (Influenza) Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Flu (Influenza) Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Flu (Influenza) Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Flu (Influenza) Vaccine Revenue by Company (2020-2022)
3.2.2 Global Flu (Influenza) Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Flu (Influenza) Vaccine Sale Price by Company
3.4 Key Manufacturers Flu (Influenza) Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Flu (Influenza) Vaccine Product Location Distribution
3.4.2 Players Flu (Influenza) Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Flu (Influenza) Vaccine by Geographic Region
4.1 World Historic Flu (Influenza) Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Flu (Influenza) Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Flu (Influenza) Vaccine Annual Revenue by Geographic Region
4.2 World Historic Flu (Influenza) Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Flu (Influenza) Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Flu (Influenza) Vaccine Annual Revenue by Country/Region
4.3 Americas Flu (Influenza) Vaccine Sales Growth
4.4 APAC Flu (Influenza) Vaccine Sales Growth
4.5 Europe Flu (Influenza) Vaccine Sales Growth
4.6 Middle East & Africa Flu (Influenza) Vaccine Sales Growth
5 Americas
5.1 Americas Flu (Influenza) Vaccine Sales by Country
5.1.1 Americas Flu (Influenza) Vaccine Sales by Country (2017-2022)
5.1.2 Americas Flu (Influenza) Vaccine Revenue by Country (2017-2022)
5.2 Americas Flu (Influenza) Vaccine Sales by Type
5.3 Americas Flu (Influenza) Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Flu (Influenza) Vaccine Sales by Region
6.1.1 APAC Flu (Influenza) Vaccine Sales by Region (2017-2022)
6.1.2 APAC Flu (Influenza) Vaccine Revenue by Region (2017-2022)
6.2 APAC Flu (Influenza) Vaccine Sales by Type
6.3 APAC Flu (Influenza) Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Flu (Influenza) Vaccine by Country
7.1.1 Europe Flu (Influenza) Vaccine Sales by Country (2017-2022)
7.1.2 Europe Flu (Influenza) Vaccine Revenue by Country (2017-2022)
7.2 Europe Flu (Influenza) Vaccine Sales by Type
7.3 Europe Flu (Influenza) Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Flu (Influenza) Vaccine by Country
8.1.1 Middle East & Africa Flu (Influenza) Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Flu (Influenza) Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Flu (Influenza) Vaccine Sales by Type
8.3 Middle East & Africa Flu (Influenza) Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Flu (Influenza) Vaccine
10.3 Manufacturing Process Analysis of Flu (Influenza) Vaccine
10.4 Industry Chain Structure of Flu (Influenza) Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Flu (Influenza) Vaccine Distributors
11.3 Flu (Influenza) Vaccine Customer
12 World Forecast Review for Flu (Influenza) Vaccine by Geographic Region
12.1 Global Flu (Influenza) Vaccine Market Size Forecast by Region
12.1.1 Global Flu (Influenza) Vaccine Forecast by Region (2023-2028)
12.1.2 Global Flu (Influenza) Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Flu (Influenza) Vaccine Forecast by Type
12.7 Global Flu (Influenza) Vaccine Forecast by Application
13 Key Players Analysis
13.1 Hualan Bio
13.1.1 Hualan Bio Company Information
13.1.2 Hualan Bio Flu (Influenza) Vaccine Product Offered
13.1.3 Hualan Bio Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hualan Bio Main Business Overview
13.1.5 Hualan Bio Latest Developments
13.2 CCBIO
13.2.1 CCBIO Company Information
13.2.2 CCBIO Flu (Influenza) Vaccine Product Offered
13.2.3 CCBIO Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CCBIO Main Business Overview
13.2.5 CCBIO Latest Developments
13.3 Aleph Biomedical
13.3.1 Aleph Biomedical Company Information
13.3.2 Aleph Biomedical Flu (Influenza) Vaccine Product Offered
13.3.3 Aleph Biomedical Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Aleph Biomedical Main Business Overview
13.3.5 Aleph Biomedical Latest Developments
13.4 SANOFI
13.4.1 SANOFI Company Information
13.4.2 SANOFI Flu (Influenza) Vaccine Product Offered
13.4.3 SANOFI Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 SANOFI Main Business Overview
13.4.5 SANOFI Latest Developments
13.5 Adimmune
13.5.1 Adimmune Company Information
13.5.2 Adimmune Flu (Influenza) Vaccine Product Offered
13.5.3 Adimmune Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Adimmune Main Business Overview
13.5.5 Adimmune Latest Developments
13.6 ZYAK
13.6.1 ZYAK Company Information
13.6.2 ZYAK Flu (Influenza) Vaccine Product Offered
13.6.3 ZYAK Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 ZYAK Main Business Overview
13.6.5 ZYAK Latest Developments
13.7 SINOVAC
13.7.1 SINOVAC Company Information
13.7.2 SINOVAC Flu (Influenza) Vaccine Product Offered
13.7.3 SINOVAC Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 SINOVAC Main Business Overview
13.7.5 SINOVAC Latest Developments
13.8 Changsheng Biological
13.8.1 Changsheng Biological Company Information
13.8.2 Changsheng Biological Flu (Influenza) Vaccine Product Offered
13.8.3 Changsheng Biological Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Changsheng Biological Main Business Overview
13.8.5 Changsheng Biological Latest Developments
13.9 SIOBP
13.9.1 SIOBP Company Information
13.9.2 SIOBP Flu (Influenza) Vaccine Product Offered
13.9.3 SIOBP Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 SIOBP Main Business Overview
13.9.5 SIOBP Latest Developments
13.10 GSK
13.10.1 GSK Company Information
13.10.2 GSK Flu (Influenza) Vaccine Product Offered
13.10.3 GSK Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 GSK Main Business Overview
13.10.5 GSK Latest Developments
13.11 Aimei Hissen
13.11.1 Aimei Hissen Company Information
13.11.2 Aimei Hissen Flu (Influenza) Vaccine Product Offered
13.11.3 Aimei Hissen Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Aimei Hissen Main Business Overview
13.11.5 Aimei Hissen Latest Developments
13.12 Tianyuan Bio-pharma(Novartis)
13.12.1 Tianyuan Bio-pharma(Novartis) Company Information
13.12.2 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Offered
13.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Tianyuan Bio-pharma(Novartis) Main Business Overview
13.12.5 Tianyuan Bio-pharma(Novartis) Latest Developments
13.13 Simcere Vaxtec
13.13.1 Simcere Vaxtec Company Information
13.13.2 Simcere Vaxtec Flu (Influenza) Vaccine Product Offered
13.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Simcere Vaxtec Main Business Overview
13.13.5 Simcere Vaxtec Latest Developments
14 Research Findings and Conclusion
Table 1. Flu (Influenza) Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Flu (Influenza) Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Split Influenza Vaccine
Table 4. Major Players of Pandemic Influenza Vaccine
Table 5. Major Players of Subunit Influenza Vaccine
Table 6. Major Players of Quadrivalent Influenza Vaccine
Table 7. Global Flu (Influenza) Vaccine Sales by Type (2017-2022) & (K Units)
Table 8. Global Flu (Influenza) Vaccine Sales Market Share by Type (2017-2022)
Table 9. Global Flu (Influenza) Vaccine Revenue by Type (2017-2022) & ($ million)
Table 10. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2017-2022)
Table 11. Global Flu (Influenza) Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Flu (Influenza) Vaccine Sales by Application (2017-2022) & (K Units)
Table 13. Global Flu (Influenza) Vaccine Sales Market Share by Application (2017-2022)
Table 14. Global Flu (Influenza) Vaccine Revenue by Application (2017-2022)
Table 15. Global Flu (Influenza) Vaccine Revenue Market Share by Application (2017-2022)
Table 16. Global Flu (Influenza) Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Flu (Influenza) Vaccine Sales by Company (2020-2022) & (K Units)
Table 18. Global Flu (Influenza) Vaccine Sales Market Share by Company (2020-2022)
Table 19. Global Flu (Influenza) Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Flu (Influenza) Vaccine Revenue Market Share by Company (2020-2022)
Table 21. Global Flu (Influenza) Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Flu (Influenza) Vaccine Producing Area Distribution and Sales Area
Table 23. Players Flu (Influenza) Vaccine Products Offered
Table 24. Flu (Influenza) Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Flu (Influenza) Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Flu (Influenza) Vaccine Sales Market Share Geographic Region (2017-2022)
Table 29. Global Flu (Influenza) Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Flu (Influenza) Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Flu (Influenza) Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Flu (Influenza) Vaccine Sales Market Share by Country/Region (2017-2022)
Table 33. Global Flu (Influenza) Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Flu (Influenza) Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Flu (Influenza) Vaccine Sales by Country (2017-2022) & (K Units)
Table 36. Americas Flu (Influenza) Vaccine Sales Market Share by Country (2017-2022)
Table 37. Americas Flu (Influenza) Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Flu (Influenza) Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Americas Flu (Influenza) Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Americas Flu (Influenza) Vaccine Sales Market Share by Type (2017-2022)
Table 41. Americas Flu (Influenza) Vaccine Sales by Application (2017-2022) & (K Units)
Table 42. Americas Flu (Influenza) Vaccine Sales Market Share by Application (2017-2022)
Table 43. APAC Flu (Influenza) Vaccine Sales by Region (2017-2022) & (K Units)
Table 44. APAC Flu (Influenza) Vaccine Sales Market Share by Region (2017-2022)
Table 45. APAC Flu (Influenza) Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Flu (Influenza) Vaccine Revenue Market Share by Region (2017-2022)
Table 47. APAC Flu (Influenza) Vaccine Sales by Type (2017-2022) & (K Units)
Table 48. APAC Flu (Influenza) Vaccine Sales Market Share by Type (2017-2022)
Table 49. APAC Flu (Influenza) Vaccine Sales by Application (2017-2022) & (K Units)
Table 50. APAC Flu (Influenza) Vaccine Sales Market Share by Application (2017-2022)
Table 51. Europe Flu (Influenza) Vaccine Sales by Country (2017-2022) & (K Units)
Table 52. Europe Flu (Influenza) Vaccine Sales Market Share by Country (2017-2022)
Table 53. Europe Flu (Influenza) Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Flu (Influenza) Vaccine Revenue Market Share by Country (2017-2022)
Table 55. Europe Flu (Influenza) Vaccine Sales by Type (2017-2022) & (K Units)
Table 56. Europe Flu (Influenza) Vaccine Sales Market Share by Type (2017-2022)
Table 57. Europe Flu (Influenza) Vaccine Sales by Application (2017-2022) & (K Units)
Table 58. Europe Flu (Influenza) Vaccine Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Flu (Influenza) Vaccine Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Flu (Influenza) Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Flu (Influenza) Vaccine Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Flu (Influenza) Vaccine Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Flu (Influenza) Vaccine Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Flu (Influenza) Vaccine
Table 68. Key Market Challenges & Risks of Flu (Influenza) Vaccine
Table 69. Key Industry Trends of Flu (Influenza) Vaccine
Table 70. Flu (Influenza) Vaccine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Flu (Influenza) Vaccine Distributors List
Table 73. Flu (Influenza) Vaccine Customer List
Table 74. Global Flu (Influenza) Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Flu (Influenza) Vaccine Sales Market Forecast by Region
Table 76. Global Flu (Influenza) Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Flu (Influenza) Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Flu (Influenza) Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Flu (Influenza) Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Flu (Influenza) Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Flu (Influenza) Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Flu (Influenza) Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Flu (Influenza) Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Flu (Influenza) Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Flu (Influenza) Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Flu (Influenza) Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Flu (Influenza) Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Flu (Influenza) Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Flu (Influenza) Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Flu (Influenza) Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 94. Hualan Bio Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Hualan Bio Flu (Influenza) Vaccine Product Offered
Table 96. Hualan Bio Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Hualan Bio Main Business
Table 98. Hualan Bio Latest Developments
Table 99. CCBIO Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. CCBIO Flu (Influenza) Vaccine Product Offered
Table 101. CCBIO Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. CCBIO Main Business
Table 103. CCBIO Latest Developments
Table 104. Aleph Biomedical Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Aleph Biomedical Flu (Influenza) Vaccine Product Offered
Table 106. Aleph Biomedical Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Aleph Biomedical Main Business
Table 108. Aleph Biomedical Latest Developments
Table 109. SANOFI Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. SANOFI Flu (Influenza) Vaccine Product Offered
Table 111. SANOFI Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. SANOFI Main Business
Table 113. SANOFI Latest Developments
Table 114. Adimmune Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Adimmune Flu (Influenza) Vaccine Product Offered
Table 116. Adimmune Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Adimmune Main Business
Table 118. Adimmune Latest Developments
Table 119. ZYAK Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. ZYAK Flu (Influenza) Vaccine Product Offered
Table 121. ZYAK Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. ZYAK Main Business
Table 123. ZYAK Latest Developments
Table 124. SINOVAC Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. SINOVAC Flu (Influenza) Vaccine Product Offered
Table 126. SINOVAC Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. SINOVAC Main Business
Table 128. SINOVAC Latest Developments
Table 129. Changsheng Biological Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Changsheng Biological Flu (Influenza) Vaccine Product Offered
Table 131. Changsheng Biological Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Changsheng Biological Main Business
Table 133. Changsheng Biological Latest Developments
Table 134. SIOBP Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. SIOBP Flu (Influenza) Vaccine Product Offered
Table 136. SIOBP Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. SIOBP Main Business
Table 138. SIOBP Latest Developments
Table 139. GSK Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. GSK Flu (Influenza) Vaccine Product Offered
Table 141. GSK Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. GSK Main Business
Table 143. GSK Latest Developments
Table 144. Aimei Hissen Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 145. Aimei Hissen Flu (Influenza) Vaccine Product Offered
Table 146. Aimei Hissen Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Aimei Hissen Main Business
Table 148. Aimei Hissen Latest Developments
Table 149. Tianyuan Bio-pharma(Novartis) Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 150. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Offered
Table 151. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Tianyuan Bio-pharma(Novartis) Main Business
Table 153. Tianyuan Bio-pharma(Novartis) Latest Developments
Table 154. Simcere Vaxtec Basic Information, Flu (Influenza) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 155. Simcere Vaxtec Flu (Influenza) Vaccine Product Offered
Table 156. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Simcere Vaxtec Main Business
Table 158. Simcere Vaxtec Latest Developments
List of Figures
Figure 1. Picture of Flu (Influenza) Vaccine
Figure 2. Flu (Influenza) Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Flu (Influenza) Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Flu (Influenza) Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Flu (Influenza) Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Split Influenza Vaccine
Figure 10. Product Picture of Pandemic Influenza Vaccine
Figure 11. Product Picture of Subunit Influenza Vaccine
Figure 12. Product Picture of Quadrivalent Influenza Vaccine
Figure 13. Global Flu (Influenza) Vaccine Sales Market Share by Type in 2021
Figure 14. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2017-2022)
Figure 15. Flu (Influenza) Vaccine Consumed in For Children (6 months to 3 years)
Figure 16. Global Flu (Influenza) Vaccine Market: For Children (6 months to 3 years) (2017-2022) & (K Units)
Figure 17. Flu (Influenza) Vaccine Consumed in For Adults and Children over 3 years
Figure 18. Global Flu (Influenza) Vaccine Market: For Adults and Children over 3 years (2017-2022) & (K Units)
Figure 19. Global Flu (Influenza) Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global Flu (Influenza) Vaccine Revenue Market Share by Application in 2021
Figure 21. Flu (Influenza) Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Flu (Influenza) Vaccine Revenue Market Share by Company in 2021
Figure 23. Global Flu (Influenza) Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Flu (Influenza) Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Flu (Influenza) Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global Flu (Influenza) Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Flu (Influenza) Vaccine Sales 2017-2022 (K Units)
Figure 28. Americas Flu (Influenza) Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Flu (Influenza) Vaccine Sales 2017-2022 (K Units)
Figure 30. APAC Flu (Influenza) Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Flu (Influenza) Vaccine Sales 2017-2022 (K Units)
Figure 32. Europe Flu (Influenza) Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Flu (Influenza) Vaccine Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Flu (Influenza) Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Flu (Influenza) Vaccine Sales Market Share by Country in 2021
Figure 36. Americas Flu (Influenza) Vaccine Revenue Market Share by Country in 2021
Figure 37. United States Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Flu (Influenza) Vaccine Sales Market Share by Region in 2021
Figure 42. APAC Flu (Influenza) Vaccine Revenue Market Share by Regions in 2021
Figure 43. China Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Flu (Influenza) Vaccine Sales Market Share by Country in 2021
Figure 50. Europe Flu (Influenza) Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Flu (Influenza) Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Flu (Influenza) Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Flu (Influenza) Vaccine in 2021
Figure 64. Manufacturing Process Analysis of Flu (Influenza) Vaccine
Figure 65. Industry Chain Structure of Flu (Influenza) Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
